ISSN: 2161-0681

Journal de pathologie clinique et expérimentale

Accès libre

Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Indexé dans
  • Index Copernic
  • Google Scholar
  • Sherpa Roméo
  • Ouvrir la porte J
  • JournalSeek de génamique
  • JournalTOC
  • Annuaire des périodiques d'Ulrich
  • Recherche de référence
  • Université Hamdard
  • EBSCO AZ
  • OCLC-WorldCat
  • Publons
  • Fondation genevoise pour l'enseignement et la recherche médicale
  • Euro Pub
  • ICMJE
Partager cette page

Abstrait

Valproate Level Variation with Menstrual Cycle Phase in Bipolar Disorder

Feng Liu, Rui Zhu, Xiaopeng Deng, Chengguo Peng, Song Qin, Bo Liu

Objectives: The purpose of this study was to investigate the changes in serum valproate (VPA) levels and their relationship to progesterone levels during the menstrual cycles of fertile women.

Materials and methods: Female patients compliant with VPA (n=14) were included in this study. Serum VPA and progesterone levels were measured during two periods, in which progesterone levels may be the lowest (early follicular phase) and the highest (mid luteal phase).

Results: Serum VPA levels were significantly different between the two periods. Serum progesterone levels increased in 64.3% of the sample during menstruation, revealed a noticeable but not significant mean increased. There was no correlation between serum valproate and progesterone levels (r=0.209, p>0.05) in the menstrual phase.

Conclusion: This study shows that serum VPA levels varied greatly during the menstrual cycles. The results of this study also implying that VPA levels may be relationship to sex steroid levels in menstrual cycle. Particularly in cyclic premenstrual exacerbation of affective symptoms, this interaction should be considered in the evaluation of treatment may be beneficial.